170 related articles for article (PubMed ID: 23106270)
21. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
Chiang CY
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
[No Abstract] [Full Text] [Related]
22. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.
Cox HS; Sibilia K; Feuerriegel S; Kalon S; Polonsky J; Khamraev AK; Rüsch-Gerdes S; Mills C; Niemann S
N Engl J Med; 2008 Nov; 359(22):2398-400. PubMed ID: 19038891
[No Abstract] [Full Text] [Related]
23. Emerging resistant clone of Mycobacterium tuberculosis in west Asia.
Mokrousov I
Lancet Infect Dis; 2016 Dec; 16(12):1326-1327. PubMed ID: 27998587
[No Abstract] [Full Text] [Related]
24. Treatment of Multidrug-resistant Tuberculosis Infection in Children.
Cruz AT; Garcia-Prats AJ; Furin J; Seddon JA
Pediatr Infect Dis J; 2018 Aug; 37(8):831-834. PubMed ID: 29742640
[No Abstract] [Full Text] [Related]
25. Rapid emergence of
Veziris N; Bernard C; Guglielmetti L; Le Du D; Marigot-Outtandy D; Jaspard M; Caumes E; Lerat I; Rioux C; Yazdanpanah Y; Tiotiu A; Lemaitre N; Brossier F; Jarlier V; Robert J; Sougakoff W; Aubry A; ;
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28182568
[No Abstract] [Full Text] [Related]
26. Drug-resistant tuberculosis.
Böttger EC
Lancet; 2001 Apr; 357(9264):1288-9. PubMed ID: 11421208
[No Abstract] [Full Text] [Related]
27. Linezolid in the treatment of drug-resistant tuberculosis: the way forward?
Yew WW; Lange C
Int J Tuberc Lung Dis; 2014 Jun; 18(6):631-2. PubMed ID: 24903928
[No Abstract] [Full Text] [Related]
28. How are we creating fluoroquinolone-resistant tuberculosis?
Bernardo J; Yew WW
Am J Respir Crit Care Med; 2009 Aug; 180(4):288-9. PubMed ID: 19661251
[No Abstract] [Full Text] [Related]
29. Direct observation therapy-plus can prevent acquired resistance to fluoroquinolones among patients with multidrug-resistant tuberculosis in Taiwan.
Chien JY; Lai CC; Tan CK; Yu CJ; Hsueh PR
Clin Infect Dis; 2013 Apr; 56(7):1054-5. PubMed ID: 23175554
[No Abstract] [Full Text] [Related]
30. [Advances in chemotherapy of multidrug-resistant and rifampicin-resistant tuberculosis].
Liu SS; Wang LZ; Tang SJ
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):371-375. PubMed ID: 32294820
[TBL] [Abstract][Full Text] [Related]
31. Fluoroquinolones in multidrug-resistant tuberculosis.
Mohapatra PR
Am J Respir Crit Care Med; 2004 Oct; 170(8):920-1. PubMed ID: 15475406
[No Abstract] [Full Text] [Related]
32. Challenges and Outlooks in Multi-drug Resistant Tuberculosis.
Caminero Luna JA
Arch Bronconeumol; 2017 Aug; 53(8):417-418. PubMed ID: 28314633
[No Abstract] [Full Text] [Related]
33. Heteroresistance in tuberculosis: are we missing drug-resistant bacteria hiding in plain sight?
Park M; Satta G; Haldar P
Thorax; 2024 Jun; 79(7):599-600. PubMed ID: 38604663
[No Abstract] [Full Text] [Related]
34. Treatment of Multidrug-Resistant Tuberculosis Infection in Children.
Cruz AT; Garcia-Prats AJ; Furin J; Seddon JA
Pediatr Infect Dis J; 2018 Oct; 37(10):1061-1064. PubMed ID: 30216296
[No Abstract] [Full Text] [Related]
35. Multidrug-resistant tuberculosis: resistance rates to first and reserve antituberculosis drugs in the UK in 2008/9 and the role of rapid molecular tests for drug resistance.
Mitchell SL; Seoudi N; Hutchison DC; Drobniewski FA
Thorax; 2011 Jul; 66(7):630-1. PubMed ID: 20880876
[No Abstract] [Full Text] [Related]
36. [Usefulness of studies on antitubercular drug resistance].
Valenzuela P
Rev Panam Salud Publica; 1997 Jan; 1(1):62-7. PubMed ID: 9162582
[No Abstract] [Full Text] [Related]
37. Acquired drug resistance: we can do more than we think!
Alffenaar JW; Gumbo T; Aarnoutse RE
Clin Infect Dis; 2015 Mar; 60(6):969-70. PubMed ID: 25527653
[No Abstract] [Full Text] [Related]
38. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
Zierski M
Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
[No Abstract] [Full Text] [Related]
39. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
Velayati AA; Farnia P; Masjedi MR; Hoffner S
Int J Tuberc Lung Dis; 2013 Jun; 17(6):849-50. PubMed ID: 23676176
[No Abstract] [Full Text] [Related]
40. [Expert Consensus on Short-Course Therapy of Multi-drug Resistant Tuberculosis].
;
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jan; 42(1):5-8. PubMed ID: 30630241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
